STOCK TITAN

Form 144: Option exercises listed; Joseph Loscalzo sold shares (IONS)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 notice of proposed sales of Common Stock tied to option exercises and recent open‑market dispositions. The filing lists multiple option‑exercise issuances dated 07/01/2021, 07/03/2023, 07/02/2018, 07/01/2020, and 07/01/2019 for 12,000; 10,321; 16,000; 12,000; and 16,000 shares respectively. It also reports that Joseph Loscalzo sold 832 shares on 03/03/2026 for $66,833 and 200 shares on 03/04/2026 for $16,000.

Positive

  • None.

Negative

  • None.

Insights

Routine Form 144 report showing option‑related issuances and two recent small insider sales.

The filing lists option exercises by the issuer across five grant dates totaling specified share counts (12,000; 10,321; 16,000; 12,000; 16,000). These entries describe securities to be sold tied to exercises, not company operational results.

Two completed dispositions by Joseph Loscalzo—832 shares for $66,833 and 200 shares for $16,000—are recorded with transaction dates 03/03/2026 and 03/04/2026. Cash proceeds and trade dates are shown directly in the listing.

Option exercise — 07/01/2021 12,000 shares listed under Securities To Be Sold
Option exercise — 07/03/2023 10,321 shares listed under Securities To Be Sold
Option exercise — 07/02/2018 16,000 shares listed under Securities To Be Sold
Sale by Joseph Loscalzo — 03/03/2026 832 shares for $66,833 Securities Sold During The Past 3 Months
Sale by Joseph Loscalzo — 03/04/2026 200 shares for $16,000 Securities Sold During The Past 3 Months
Form 144 regulatory
"144: Securities To Be Sold"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Option Exercise financial
"Common Stock | 07/01/2021 | Option Exercise"
Issuer financial
"Option Exercise | Issuer | | | 12000"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does IONS Form 144 disclose about proposed sales?

The filing lists proposed sales tied to option exercises for specific grant dates and share counts. It details option exercise issuances of 12,000; 10,321; 16,000; 12,000; and 16,000 shares on the listed grant dates.

Who sold shares recently according to the filing for IONS?

Joseph Loscalzo reported two recent sales: 832 shares sold on 03/03/2026 for $66,833 and 200 shares sold on 03/04/2026 for $16,000. The filing shows trade dates and proceeds.

Are the option exercises reported as issuer transactions or open‑market sales?

The option exercises are listed with the method labeled Issuer, indicating exercises resulting in shares issued by the company. The filing pairs those items with the payment method labeled Cash.

Does the Form 144 show total proceeds expected from the proposed sales?

The filing lists cash proceeds for completed past sales by Joseph Loscalzo but does not present an aggregate expected proceeds figure for the option‑related proposed sales in the excerpt provided.

What dates are associated with the option grants shown in the filing?

Grant or grant‑related dates shown include 07/01/2021, 07/03/2023, 07/02/2018, 07/01/2020, and 07/01/2019, each paired with the respective share counts listed in the filing.